| Dr Genevieve A Lankowicz, MD | |
|
600 East Blvd, West Wing, Elkhart, IN 46514-2483 | |
| (574) 523-2751 | |
| (574) 389-4840 |
| Full Name | Dr Genevieve A Lankowicz |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 600 East Blvd, Elkhart, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174522783 | NPI | - | NPPES |
| 000000725535 | Other | IN | ANTHEM BCBS - FMC |
| 000000202811 | Other | IN | ANTHEM BCBS # |
| 000000526016 | Other | IN | ANTHEM BCBS # |
| 200356850A | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01054719A (Indiana) | Primary |
| Entity Name | Lakeland Immediate Care Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982677548 PECOS PAC ID: 2264423771 Enrollment ID: O20040524000042 |
News Archive
A study carried out by researchers from the Department of Radiology and Physical Medicine of the University of Granada, in collaboration with the Andalusian School of Public Health (Escuela Andaluza de Salud Publica), found that 100% of Spaniards analyzed had at least one kind of persistent organic compound (POC's), substances internationally classified as potentially harmful to one's health, in their bodies.
Specially designed nanoparticles can reveal tiny cancerous tumors that are invisible by ordinary means of detection, according to a study by researchers at Washington University School of Medicine in St. Louis.
Champions Biotechnology, Inc., a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, has established yet another agreement with a large biotechnology company for the evaluation of a novel oncology therapeutic in Champions' Biomerk Tumorgraft(TM) platform.
Merck & Co., Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved ZEGERID OTC(TM) (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules), for over-the-counter treatment of frequent heartburn.
An international team of researchers led by Cleveland Clinic has developed new genetic-based epilepsy risk scores which may lay the foundation for a more personalized method of epilepsy diagnosis and treatment.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Genevieve A Lankowicz, MD Po Box 660376, Indianapolis, IN 46266-0376 Ph: (574) 523-3148 | Dr Genevieve A Lankowicz, MD 600 East Blvd, West Wing, Elkhart, IN 46514-2483 Ph: (574) 523-2751 |
News Archive
A study carried out by researchers from the Department of Radiology and Physical Medicine of the University of Granada, in collaboration with the Andalusian School of Public Health (Escuela Andaluza de Salud Publica), found that 100% of Spaniards analyzed had at least one kind of persistent organic compound (POC's), substances internationally classified as potentially harmful to one's health, in their bodies.
Specially designed nanoparticles can reveal tiny cancerous tumors that are invisible by ordinary means of detection, according to a study by researchers at Washington University School of Medicine in St. Louis.
Champions Biotechnology, Inc., a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, has established yet another agreement with a large biotechnology company for the evaluation of a novel oncology therapeutic in Champions' Biomerk Tumorgraft(TM) platform.
Merck & Co., Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved ZEGERID OTC(TM) (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules), for over-the-counter treatment of frequent heartburn.
An international team of researchers led by Cleveland Clinic has developed new genetic-based epilepsy risk scores which may lay the foundation for a more personalized method of epilepsy diagnosis and treatment.
› Verified 9 days ago
Jason J Hix, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2310 California Road, Elkhart, IN 46514 Phone: 574-264-4163 Fax: 574-262-9650 | |
Dr. David M Dyck, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3301 County Road 6 E, Elkhart, IN 46514 Phone: 574-264-9635 Fax: 574-262-0398 | |
Sam Joseph Borrelli, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 25651 County Road 20, Elkhart, IN 46517 Phone: 574-522-1201 | |
Saadia Qasim, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3301 County Road 6 E, Elkhart, IN 46514 Phone: 574-264-9635 Fax: 574-262-0398 | |
Lydia K Mertz, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 608 Oakland Ave, Elkhart, IN 46516 Phone: 574-523-2127 Fax: 574-522-2192 | |
Susan Marie Moore-riesbeck, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 28070 County Road 24, Elkhart, IN 46517 Phone: 574-273-8053 Fax: 574-273-8056 |